OBM Genetics

(ISSN 2577-5790)

OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes research articles, reviews, communications and technical notes, etc. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Archiving: full-text archived in CLOCKSS.

Publication Speed (median values for papers published in 2022): Submission to First Decision: 4 weeks; Submission to Acceptance: 12 weeks; Acceptance to Publication: 13 days (1-2 days of FREE language polishing included)

Current Issue: 2023  Archive: 2022 2021 2020 2019 2018 2017

Special Issue

Microbiome Studies of Respiratory and Gastrointestinal Diseases

Submission Deadline: October 15, 2024 (Open) Submit Now

Guest Editor

Ahmad R. Alsayed, PhD, Associate Professor

Therapeutics and Precision Medicine, Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan

Website | E-Mail

Research Interests: microbiome dysbiosis; microbiome health; pharmacogenomics; drug development

About This Topic

The intricate interplay between the human microbiome and the respiratory and gastrointestinal systems has garnered significant attention in recent years. Advances in sequencing technologies and bioinformatics have unveiled the complex relationships between microbial communities and health outcomes. This special issue aims to explore the latest developments in microbiome research related to respiratory and gastrointestinal diseases. By examining these two interconnected systems, we seek to enhance our understanding of the microbiome's role in health and disease.

We invite researchers from diverse disciplines to contribute their original research, reviews, and perspectives on various facets of microbiome studies in the context of respiratory and gastrointestinal diseases. Topics of interest include, but are not limited to:

  1. Microbiome Dysbiosis and Disease Associations: Investigate the alterations in the respiratory and gastrointestinal microbiomes with diseases such as asthma, inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), pneumonia, and more. 
  2. Cross-Talk Between Systems: Explore the interactions and potential cross-talk between the respiratory and gastrointestinal microbiomes, considering the impact on disease development and progression. 
  3. Immunomodulation and Host-Microbiome Interactions: Examine the intricate immunomodulatory mechanisms triggered by the microbiome in both the respiratory and gastrointestinal systems and their relevance to disease outcomes. 
  4. Therapeutic Strategies: Highlight microbiome-based therapeutic interventions targeting both systems, including fecal microbiota transplantation, probiotics, prebiotics, and postbiotics, as well as their potential synergistic effects. 
  5. Diagnostic and Prognostic Biomarkers: Present novel approaches for utilizing microbiome profiles as diagnostic and prognostic biomarkers for respiratory and gastrointestinal diseases. 
  6. Nutrition, Lifestyle, and Microbiome Health: Investigate the influence of nutrition, lifestyle choices, and environmental factors on shaping the microbiomes of both systems and their implications for disease risk and management. 
  7. Bioinformatics and Multi-Omics Approaches: Share innovative bioinformatics methodologies and multi-omics strategies for dissecting the complex microbial communities and interactions involved in these diseases.